Conte: "Legal initiatives for compliance with contractual vaccine commitments"
Share
January 23, 2021 At the end of March, about 15 million doses of the vaccine will be delivered in Italy.
This is what the Commissioner for the Emergency, Domenico Arcuri, would have said during the meeting with the Regions.
Arcuri said that at the moment from AstraZeneca, if approved by Ema on January 29, we will not have the 8 million previously insured, but 3.4 by the end of March, in addition to the doses of Moderna and Pfizer.
The first delivery of AstraZeneca's vaccine is expected to be made on February 15th.
The other two deliveries would instead be scheduled for February 28 and March 15.
Off to action against Pfizer
'' On Monday, the State Attorney's Office will have completed the investigations and we will be able to proceed against Pfizer on the channels already shared, therefore with a warning for non-compliance on the national territory;
a complaint for potential damage to health with an Italian prosecutor and the request to the Brussels court for non-compliance on behalf of the Italian government and the Regions, '' said Arcuri, during the summit with the Regions and the Minister of Health, Roberto Hope, convened by the Minister for Regional Affairs, Francesco Boccia.
Arcuri-De Luca
dispute In today's meeting, there was a bitter quarrel between Arcuri and the Campania governor De Luca.
According to the Ansa agency, in the online summit, De Luca underlined the inequality in the distribution plan, which he had already expressed in yesterday's Facebook direct, asking for a rebalancing.
A speech that led to a direct confrontation with Arcuri.
"We have witnessed the black market of vaccines - De Luca said yesterday - it is time to stop worrying, we will come to ask for the distribution plan to be invalidated".
Hope: "Reithera vaccine to be enhanced"
The Reithera vaccine is "to be enhanced as much as possible".
According to what is learned, the Minister of Health, Roberto Speranza, said this during the meeting with the Regions.